Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Asthma-IV: Nursing Management

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026

Same author

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026

Same author

Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.

The New England journal of medicine·2026

Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026

Same author

Remote Multicomponent Rehabilitation in Intensive Care Unit Survivors: A Randomized Clinical Trial.

JAMA·2026

Same author

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

The Lancet. Respiratory medicine·2026

Same journal

British Thoracic Society quality standard for pulmonary rehabilitation.

BMJ open respiratory research·2026

Same journal

Maternal, Infant, Reproductive and Child Health in Cystic Fibrosis (MATRIARCH_CF): a prospective, observational study to evaluate pregnancy and parenthood in females with cystic fibrosis and health of the offspring in the CFTR-modulator era.

BMJ open respiratory research·2026

Same journal

Maternal asthma activity and offspring asthma: a linked-data population study in Australia and Sweden.

BMJ open respiratory research·2026

Same journal

Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial.

BMJ open respiratory research·2026

Same journal

GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA).

BMJ open respiratory research·2026

Same journal

Current use and future potential of oscillometry in UK lung function testing: a national survey.

BMJ open respiratory research·2026

Ver todos los artículos relacionados

Search research articles

Video Experimental Relacionado

Updated: Sep 9, 2025

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

Mejorar la toma de decisiones compartida en la bronquiectasia

Paul McCallion^1,2, Judy M Bradley³, Adam Lewis⁴

¹Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK paul.mccallion@nhs.net.

BMJ open respiratory research

|September 3, 2025

Resumen

Este resumen es generado por máquina.

La medicina personalizada en la bronquiectasia está creciendo. La toma de decisiones compartida (SDM) puede mejorar la elección del paciente y la adherencia a las técnicas de limpieza de las vías respiratorias (ACT), tratamientos no farmacológicos esenciales.

Palabras clave:

Las bronquiectasias

Más Videos Relacionados

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Área de la Ciencia:

Pulmonología
Medicina personalizada
Psicología de la salud

Sus antecedentes:

La bronquiectasia es una afección pulmonar compleja que requiere tratamiento individualizado.
El manejo actual incluye enfoques farmacológicos y no farmacológicos como las técnicas de despeje de las vías respiratorias (ACT).
La adherencia de los pacientes a las ACT es variable, lo que pone de relieve la necesidad de mejorar la personalización.

Objetivo del estudio:

Explorar el papel de la toma de decisiones compartida (SDM) en la personalización de las recetas de ACT para la bronquiectasia.
Investigar cómo el SDM puede mejorar la elección del paciente y la adherencia a las ACT.
Esbozar los pasos para desarrollar una intervención de MDS para los TCA en la bronquiectasia.

Principales métodos:

Revisión de la literatura sobre la medicina personalizada y el SDM en la bronquiectasia.
Discusión de las directrices y desafíos actuales en la prescripción de ACT.
Marco conceptual para una intervención de MDS.

Principales resultados:

La literatura existente no se centra en la preferencia del paciente en la prescripción de ACT para la bronquiectasia.
SDM ofrece un marco para integrar la elección del paciente en la selección de ACT y la adherencia.
Una intervención de SDM podría empoderar a los pacientes y mejorar el compromiso con los ACT.

Conclusiones:

La toma de decisiones compartida (SDM) tiene un potencial significativo para personalizar las técnicas de despeje de las vías respiratorias (ACT) en la bronquiectasia.
La implementación de SDM puede empoderar a los pacientes, mejorar la comprensión de la importancia de ACT y mejorar la adherencia.
Se necesitan más investigaciones para desarrollar y evaluar intervenciones de SDM para ACTs en bronquiectasias.